Key result
Epicardial delivery of adipose-derived stromal cell sheets resulted in a higher survival rate than intramyocardial cell injections in rats with chronic MI.
Why the study?
Does epicardial delivery of ADSC sheets improve survival and left ventricular remodeling compared to intramyocardial injection in a rat model of chronic myocardial infarction?
RCT (n=82)
Assessor-blind
randomized
Does epicardial delivery of ADSC sheets improve survival and left ventricular remodeling compared to intramyocardial injection in a rat model of chronic myocardial infarction?
Epicardial delivery of adipose-derived stromal cell sheets improves survival and preserves left ventricular geometry better than intramyocardial cell injections in a rat model of chronic myocardial infarction.
Answers are grounded in this paper and cite their sources.
Caution against clinical use of epicardial ADSC sheets; extends preclinical delivery data but leaves human translation open.
AIMS: Intramyocardial injections of cells can damage tissue and enhance dissociation-induced cell death. We assessed whether epicardial delivery of cell sheets could overcome these issues in a rat model of chronic myocardial infarction. METHODS AND RESULTS: Eighty-two rats that had undergone coronary ligation and simultaneous harvest of fat tissue to yield the adipose-derived stromal cell (ADSC) fraction were randomized 1 month after infarction to receive injections of either control medium (n= 24) or 10 × 10(6) autologous ADSC (n= 37) or the epicardial deposit, onto the infarcted area, of a trilayered ADSC sheet (10 × 10(6), n= 21) prepared by culturing cells on temperature-sensitive dishes. Some treated rats received green fluorescent protein labelled ADSC. Survival, function, and cell engraftment were blindly assessed after 2 months. Prior to implantation, cell sheets and suspended cells were assessed for the expression of extracellular matrix constituents and molecules involved in angiogenesis and cardiac remodelling. The survival rate of rats receiving the cell sheets was significantly higher than after cell injections (73 vs. 41%, P = 0.01). This correlated with the absence of left ventricular (LV) remodelling in the cell sheet group, as end-diastolic volume only increased by 2.8% compared with baseline [95% confidence interval (CI): -18.7%; +30.0%, P = 0.81] vs. increases of 25.9% (-0.4%; +59.2%, P = 0.05) and 51.2% (+18.6%; +92.8, P = 0.001) in the cell and medium injection groups, respectively. Sheets also resulted in a greater cell engraftment possibly related to the greater expression of extracellular matrix constituents. CONCLUSION: The better preservation of LV geometry afforded by ADSC sheets is associated with increased survival and engraftment, which supports the concept of an epicardial delivery of cell-seeded biomaterials.
No takes yet. Share an insight, caveat, or question.
Hamdi et al. (2011) conducted an RCT in chronic myocardial infarction (n=82). Epicardial deposit of a trilayered ADSC sheet vs. Intramyocardial injections of autologous ADSC or control medium was evaluated on Survival rate (p=0.01). Epicardial delivery of adipose-derived stromal cell sheets resulted in a higher survival rate than intramyocardial cell injections in rats with chronic MI.
Synapse has enriched 10 related papers. Consider them for comparative context: